chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain in the right arm at and around the injection site.; Extreme soreness; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the right arm on 27Feb2021 at 09:15 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included bupropion (MANUFACTURER UNKNOWN) and multivitamin; both taken for an unknown indication on an unknown date and unknown if ongoing. On 27Feb2021 at 09:30, the patient experienced extreme soreness/ pain in the right arm at and around the injection site. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event extreme soreness/pain in the right arm at and around the injection site was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Had approximately 5 episodes of feeling like she could not breathe or swallow between 11:00 PM on 11/9/05 and 1:40 AM on 11/10/05. I still have neck tightness as of 3:00 PM 11/10/05. Advised to contact her physician.
pt recvd vax & formed knot on leg 1 diam & bruising;
Sore arm; This is a spontaneous report from a contactable other health care professional. A 23-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EJI685), intramuscular on 23Dec2020 04:00 at single dose at arm right for COVID-19 immunization. The patient's medical history was reported as none. Concomitant medications included sertraline hydrochloride (ZOLOFT), and desvenlafaxine succinate (PRISTIQ). On 24Dec2020 08:00, the patient experienced sore arm. The patient did not receive treatment for the event. The outcome of the event was recovered.
Within 3-5 minutes, she was asking for water and feeling hot.  Her back was sweaty. Her eyes looked like they were glazed- not responding; didn't look bright. She got some water and an ice pack on her back and removed her shoes and put her feet up. After drinking the water and keeping the ice pack on for the rest of those 15 minutes. Nurses were there watching her. And she was able to walk out of the clinic on her own power. It had looked like she maybe would have passed out without the intervention of water, ice pack and getting her feet up.  She had muscle pain in her arm (of injection site)  that day and into the next day. The muscle pain in her arm lasted for about 24 hours.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2010, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster or shingles. In 2015, the patient was treated by [name of health care system] for a vesicular outbreak which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown.  Causality assessment was related. Additional information has been requested.
Acute Bronchitis diagnosed on 12/12/2021 and now have to be on 3 medication asthma medication. Never had issued with breathing nor have any prior asthma. Develop high blood pressure and had be on medication to control blood pressure. Experience chest pain (like a heavy blanket over my chest) since 12/12/2021 up to present. Never had issues with blood pressure nor chest pain.  Prior to vaccine, I only have 3 daily meds. Now, I am on 2 ongoing BP meds and 2 ongoing Pulmonary meds. My Pulmonary doctor confirmed that my lungs are suffering form inflamation. Currently waiting for my ECHO results and EKG monitor results from my Cardiologist.
No known adverse effects; a patient received an epxired dose of M-M-R II; a patient received an expired dose of M-M-R II via intramuscular route; This spontaneous report was received from a physician and refers to a patient of an unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 12-APR-2019, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) rHA (recombinant human albumin) lot # M029229, expiration date: 08-JUN-2018, intramuscularly (exact dose was not provided). No known adverse effects were reported.
My Father starting experiencing all the side affects - chills/shaking/loss of energy /fever and passed away - the day after having the shot.
11:15. Patient had fainted after her first vaccination, so we had her receive the second dose in a quiet, secluded part of clinic.  Shortly after the 2nd dose, she said she felt weak, and slumped in her chair. She was assisted to the floor. EMS and NP in attendance.  Patient was quiet but anxious. VS 144/84; HR 99;  r 22-25/  Pulse oximeter 100 on RA. Fingerstick glucose 111 @ 11:20 am. Patient was more awake, talking about her family.  Her cousin and sister in law were in attendance as well.  Continued her observation period in the quiet environment. Recovered without incident and left at 11:40 am.
Rash, high fever for over 24hrs (102.7-103.8), severe bone pain , severe back pain preventing daily activities such as walking
Injection hurt going in and pulling out. Soreness excruciating at 10:30 pm. Couldn?t sleep. Felt really tired starting at 10:30   At 8am had 100.7 fever. Felt weak, fluey and lightheaded. Legs wobbly when getting out of bed. Stayed in bed til 3 pm when  Temp 99.7. Started feeling better at 6 pm.   Got up. Arm still sore. Next day still felt light headed but temp normal. Developed a sore 2x3 inch bump on inside of my left arm that is sore. Doctor said injection hit a blood vessel and I have a hematoma   Injection site soreness almost gone   Inexperienced young girl gave me vaccine. Really hurt unlike the first shot which didn?t even hurt. Think she needs more training on how to administer injections
Large boil appeared on back of left shoulder, about the size of a tennis ball.  Became infected very quickly.  Neither Pharmacy nor urgent care would touch it.  Had to go to surgeon to have it dealt with.  The boil had spawned many cists that had to be removed.  It left a hole in the shoulder about 2-3 inches deep!!  It was black and very nasty looking!!!!!
Inf received 6 mon vaccinations at 2 hrs after he ran a Temp of 100.4 and large warm red lumps formed at inj sites. Tylenol and bath given with some relief. 24 hrs after vaccinations rash on legs then belly then arms and face started. Mom took inf to MD on 3rd day. Both eyes were red also. Medicated with Prednisone 5mg/5ml; 1/2Tsp BID
I woke up with my face and lips swollen. My lips were extremely dry and puffy and they constantly cracked and bled. The corners of my mouth would crack and bleed every time I opened my mouth wide, such as to floss my teeth. My taste bus were completely off kilter. Chocolate tasted like lemon; water tasted salty, and spicy foods which I love, were unbearable to the point where I felt like I had eaten acid. This lasted all the way through July.
Information was received 11-JUL-2017 via a phone call from a medical assistant who reported that a female patient of unspecified age was inadvertently administered one expired dose of MMR II on 11-JUL-2017 (Lot number L024268, expiration date 01-JUL-2017). Concomitant Merck sterile diluent was used (Lot number M047667, expiration date 25-JUL-2019). No adverse effects were reported. No further information was reported. Additional information was requested.
administered Moderna Covid-19 vaccines beyond the 30 day use by date to 20 patients; administered Moderna Covid-19 vaccines beyond the 30 day use by date to 20 patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered Moderna Covid-19 vaccines beyond the 30 day use by date to 20 patients) and PRODUCT STORAGE ERROR (administered Moderna Covid-19 vaccines beyond the 30 day use by date to 20 patients) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045L21A, 026B21A and 027A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Mar-2022 at 10:00 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 03-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered Moderna Covid-19 vaccines beyond the 30 day use by date to 20 patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (administered Moderna Covid-19 vaccines beyond the 30 day use by date to 20 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered Moderna Covid-19 vaccines beyond the 30 day use by date to 20 patients) and PRODUCT STORAGE ERROR (administered Moderna Covid-19 vaccines beyond the 30 day use by date to 20 patients) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by the reporter.  On 19-Jan-2022, The vial was initially stored in the refrigerator.  No temperature excursions were reported.  No treatment medication was reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 04-Mar-2022: Follow-up information included no new information.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider(s) recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In DECEMBER 2011, a pharmacist at a pharmacy administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 19-FEB-2012, the patient was treated by a healthcare provider at a hospital for shingles. The patient was diagnosed with shingles and or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of patient's injuries. As a direct and proximate result of ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (not specified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was not recovered. Causality assessment was related. Additional information has been requested.
This spontaneous case initially received on 20-Sep-2016, was reported by a health professional and concerns a female patient. Weight: not provided; Height: not provided. Administration of company suspect drug(s): On an unknown date, the patient received AFLURIA. Dose: 0.5 ml, Route of administration: Intramuscular. Batch number: WT53606. No additional suspect drugs. On an unknown date, the patient was administered AFLURIA vaccines that were out of range at 50.1F for 1 hour and 27 minutes - no adverse event (outcome: not reported, special circumstances: drug administration error without adverse event). Reporter comments: The reporter considered the event as non-serious.
Information has been received from a physician concerning a female who on 24-JUL-2007 was vaccinated with the third dose of Gardasil.  On 24-JUL-2007, the patient experienced injection site pain.  The patient was scheduled for an appointment to be seen in the office on 30-AUG-2007.  At the time of this report, the patient was not recovered.  Additional information has been requested. Initial and follow-up information has been received from a health professional concerning a 26 year old white female who on 24-JUL-2007 was vaccinated IM in the left deltoid with the third dose of GARDASIL (lot #0469U). On 24-JUL-2007, the patient experienced persistent pain at the left deltoid injection site without a visible lesion. It was also reported that the patient's shoulder was increasingly painful with movement at the injection site. The patient was scheduled for an appointment to be seen in the office on 30-AUG-2007. At the time of this report, the patient's pain was resolving and was described as "once a week and brief." Additional information is not expected.
thinning of her hair; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date, the patient experienced thinning of her hair following the vaccine doses. The outcome of event was unknown.   No follow-up attempts are possible. information about lot/batch number cannot be obtained. No further information is expected.
Felt like revved up/Revved up, like a little hyper; This is a spontaneous report from a contactable consumer. A 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history included palpitations from unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient was not pregnant. The patient stated, "I did have the first injection this past Sunday. What I felt was like, I felt like I was just revved up a little bit. They had us sit for half hour and because of what I was feeling they had me to sit another 10 minutes and it pretty much passed. I did feel a little bit later that day, even up till today, just once in a while during the day. I am concerned about the second injection with that concern. And I am hearing things like we all do. I don't know what you know whether it's your drug or (other vaccine branded) that I am hearing conversation about, the second injection creating more of a reaction possibly even COVID like with fever or nausea or aching. What can I expect and is there anything I should do or be aware of with the feeling that I had of this revving up a little bit? I don't know if you, when I say revved up, like it wasn't quite palpitations because I have had that before but just revved up, I don't know how else to describe it. It didn't last very long. It just passes. Revved up, like a little hyper. I just calm myself, try to relax and calm myself." The outcome of the event was unknown.  Information on lot/batch number has been requested.
Pt was administered TDAP right del and flu vax left del. On 10/12/10 she noticed a bump at inj site of left arm with redness and itching. Advised to try BENADRYL and contact our office within the day to give update on status. No return call.
Patient began to get lightheaded and dizzy. Patient was laid down and feet elevated. Patient begin to have beginning signs of a seizure but mom intervened by talking with patient and patient begin to talk to mom and patient responded by. Patient was unable to stand without being lightheaded so patient was sent to the ER.
Pt was given 2nd dose of JSN, did not show that he was given one at 3/23/2021. Patient denied every taking COVD-19 injection before.
Caller states that she received her 1st Pfzier vaccine on  03/31/2021.  At approx 4:00 pm, noted " chest heaviness, swelling of her throat with a cough".  Appears to be in  no acute distress, denies difficulty of breathing and able to speak in clear, complete sentences.  Instructed to seek emergency care for an evaluation.
Initial medication error report received on 09-OCT-2013 from a pharmacist. An under 7 years old child whose gender, medical history and concomitant medications were not reported, received a dose of ADACEL (lot number, route and site of vaccination was not reported) on an unspecified date. Pharmacist stated reported that Tdap inadvertently administered instead of Dtap to a child under 7 years. List of documents held by sender: none.
Swollen lymph nodes under arms and in groin, headache, pain at injection site, tiredness, fever, chills, felt unwell
Experienced low grade fever, migraine like headache, and extreme body aches. Sought treatment and COVID-19 testing from hospital. COVID-19 was negative. Hospital administered Tylenol, Toradol and Zofran to address symptoms.
Fever following vax w/Engerix-B; h/a & dizziness 2 days p/vax;
Sore Arm; Sluggish; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm) and SLUGGISHNESS (Sluggish) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Emphysema and COPD.    On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore Arm) and SLUGGISHNESS (Sluggish). At the time of the report, PAIN IN EXTREMITY (Sore Arm) and SLUGGISHNESS (Sluggish) outcome was unknown.
About 5 to 6 weeks after my third Moderna full-dose vaccine my immune system became 'revved'.  I haven't felt like that since the earliest days after my initial diagnosis twenty-two years ago.  I can no longer control the inflammation by just taking Enbrel, swimming daily and eating no added sugars as I have for years.  I have had to take Meloxicam for relief.  Also, Methotrexate is being added to my regimen of drugs.  I fear that taking the booster in March 2022 will rev my immune system again and further advance my RA.
I indicated on my v-safe check in that I did not believe this new health condition is a result of the vaccine but have been directed by you all to fill this out. On 9/18/22 I started experiencing right foot numbness, that then started climbing up my right leg, entire R arm numb and L hand as well. I was taken by ambulance to ED, dx of Complex Migraine. Migraine is not present still but numbness remains. I am also experiencing dropping things and sometimes tripping. Brain MRI r/o MS, but no other testing was done at the ED. I will have a nerve conduction study 11/9/22.
persistent light pink, rectangular papule 5 x 7cm. Not hot/red/tender/itchy. Started within several days & has persisted x 3 weeks. Vaccine administered at urgent care clinic. Lot number not available.
fever to 103; swollen thigh fussy 31MAR; better 1APR then fever again 2&3APR;
Two weeks after vaccine, I got a period while post-menopausal. Endocrinologist had confirmed menopause in 2019 with FSH 159. I had not menstruated since 2019 at all until vaccine.; This is a spontaneous report from a contactable consumer. A 48-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 31Mar2021 02:00 (Batch/Lot Number: ER8733) as 2ND DOSE, SINGLE for covid-19 immunisation. Medical history included Adenomyosis, pelvic mass, hypermobility syndrome, menopause from 2019 to an unknown date Endocrinologist had confirmed menopause in 2019 with FSH 159. I had not menstruated since 2019 at all until vaccine. The patient received first dose of BNT162B2 for COVID-19 immunisation on 10Mar2021 (Batch/lot number: EN6206   Anatomical Location: Arm Left). Concomitant medications included vitamin d [vitamin d nos] (VITAMIN D); vitamin k2 [menaquinone] (VITAMIN K2); cyanocobalamin (VIT B12) taken for an unspecified indication, start and stop date were not reported. The patient previously took penicillin [benzylpenicillin potassium], and sulfonamides and experienced Known allergies. Two weeks after vaccine, I got a period while post-menopausal. Endocrinologist had confirmed menopause in 2019 with FSH 159. I had not menstruated since 2019 at all until vaccine. The patient underwent lab tests and procedures which included blood follicle stimulating hormone: 159 in 2019. Therapeutic measures were taken as a result of the event. The outcome of the event was unknown.   Information on batch/lot number was obtained. Further information has been requested.
Fever, chills and bodyaches.  Did not receive medical treatment, symptoms stopped after 3 days
Patient missed the 2nd dose; Patient is likely to get the 2nd shot beyond the interval of 42 days.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient missed the 2nd dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient is likely to get the 2nd shot beyond the interval of 42 days.) in a patient of an unknown age and gender who received mRNA-1273 for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient missed the 2nd dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient is likely to get the 2nd shot beyond the interval of 42 days.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient missed the 2nd dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient is likely to get the 2nd shot beyond the interval of 42 days.) had resolved.        For mRNA-1273 (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  No concomitant medication was provided.
Systemic: Patient started with a fever overnight beginning at 9pm, got up and went to work and started developing shortness f breath and chest pain. She worked for 6 hours and went to the ER. She was diagnosed with a UTI and elevated troponin levels-Severe, Additional Details: Her BP on admission was 178/100, troponin levels went down, she was NPO the next day and then went home.
"Right deltoid burned on injection and keep burning". It became hard to move by the next morning it was swollen and red. Treatment- watch applied heat. Gone by Sunday Sept 6 2009.